Current Trends of the Incidence and Pathological Diagnosis of Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) in Korea 2000-2009: Multicenter Study
2
조회
0
다운로드
28
인용
0
참고문헌
키워드
초록
Purpose As a result of various independently proposed nomenclatures and classifications, there is confusion in the diagnosis and prediction of biological behavior of gastroenteropancreatic neuroendocrine tumors (GEP-NETs). A comprehensive nationwide study is needed in order to understand the biological characteristics of GEP-NETs in Korea. Materials and Methods We collected 4,951 pathology reports from 29 hospitals in Korea between 2000 and 2009. Kaplan-Meier survival analysis was used to determine the prognostic significance of clinicopathological parameters. Results Although the GEP-NET is a relatively rare tumor in Korea, its incidence has increased during the last decade, with the most significant increase found in the rectum. The 10-year survival rate for well-differentiated endocrine tumor was 92.89%, in contrast to 85.74% in well differentiated neuroendocrine carcinoma and 34.59% in poorly differentiated neuroendocrine carcinoma. Disease related death was most common in the biliary tract (62.2%) and very rare in the rectum (5.2%). In Kaplan-Meier survival analysis, tumor location, histological classification, extent, size,mitosis, Ki-67 labeling index, synaptophysin expression, lymphovascular invasion, perineural invasion, and lymph node metastasis showed prognostic significance (p＜0.05), however, chromogranin expression did not (p=0.148). The 2000 and 2010 World Health Organization (WHO)classification proposals were useful for prediction of the prognosis of GEP-NET. Conclusion The incidence of GEP-NET in Korea has shown a remarkable increase during the last decade,however, the distribution of tumors in the digestive system differs from that of western reports. Assessment of pathological parameters, including immunostaining, is crucial in understanding biological behavior of the tumor as well as predicting prognosis of patients with GEP-NET.
Abstract
Purpose As a result of various independently proposed nomenclatures and classifications, there is confusion in the diagnosis and prediction of biological behavior of gastroenteropancreatic neuroendocrine tumors (GEP-NETs). A comprehensive nationwide study is needed in order to understand the biological characteristics of GEP-NETs in Korea. Materials and Methods We collected 4,951 pathology reports from 29 hospitals in Korea between 2000 and 2009. Kaplan-Meier survival analysis was used to determine the prognostic significance of clinicopathological parameters. Results Although the GEP-NET is a relatively rare tumor in Korea, its incidence has increased during the last decade, with the most significant increase found in the rectum. The 10-year survival rate for well-differentiated endocrine tumor was 92.89%, in contrast to 85.74% in well differentiated neuroendocrine carcinoma and 34.59% in poorly differentiated neuroendocrine carcinoma. Disease related death was most common in the biliary tract (62.2%) and very rare in the rectum (5.2%). In Kaplan-Meier survival analysis, tumor location, histological classification, extent, size,mitosis, Ki-67 labeling index, synaptophysin expression, lymphovascular invasion, perineural invasion, and lymph node metastasis showed prognostic significance (p＜0.05), however, chromogranin expression did not (p=0.148). The 2000 and 2010 World Health Organization (WHO)classification proposals were useful for prediction of the prognosis of GEP-NET. Conclusion The incidence of GEP-NET in Korea has shown a remarkable increase during the last decade,however, the distribution of tumors in the digestive system differs from that of western reports. Assessment of pathological parameters, including immunostaining, is crucial in understanding biological behavior of the tumor as well as predicting prognosis of patients with GEP-NET.
참고문헌 (25)
- Kloppel G, "The gastroenteropancreatic neuroendocrine cell system and its tumors : the WHO classification", Ann N Y Acad Sci, 1014, pp.13~27 (2004)
- Kloppel G, "ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors : towards a standardized approach to the diagnosis of gastroenteropancreatic neuroendocrine tumors and their prognostic stratification", Neuroendocrinology, 90, pp.162~166 (2009)
- Klimstra DS, "The pathologic classification of neuroendocrine tumors : a review of nomenclature, grading, and staging systems", Pancreas, 39, pp.707~712 (2010)
- Bosman FT, "WHO classification of tumours of the digestive system. 4th ed" (2010), International Agency for Research on Cancer
- Kloppel G, "Site-specific biology and pathology of gastroenteropancreatic neuroendocrine tumors", Virchows Arch, 451(Suppl 1), pp.S9~S27 (2007)
- Boudreaux JP, "The NANETS consensus guideline for the diagnosis and management of neuroendocrine tumors : well-differentiated neuroendocrine tumors of the jejunum, ileum, appendix, and cecum", Pancreas, 39, pp.753~766 (2010)
- Washington MK, "Protocol for the examination of specimens from patients with neuroendocrine tumors(carcinoid tumors)of the colon and rectum", Arch Pathol Lab Med, 134, pp.176~180 (2010)
- Edge SB, "The American Joint Committee on Cancer : the 7th edition of the AJCC cancer staging manual and the future of TNM", Ann Surg Oncol, 17, pp.1471~1474 (2010)
- Klimstra DS, "Pathology reporting of neuroendocrine tumors : application of the Delphic consensus process to the development of a minimum pathology data set", Am J Surg Pathol, 34, pp.300~313 (2010)
- Vinik AI, "NANETS consensus guidelines for the diagnosis of neuroendocrine tumor", Pancreas, 39, pp.713~734 (2010)
- Rindi G, "TNM staging of foregut(neuro)endocrine tumors : a consensus proposal including a grading system", Virchows Arch, 449, pp.395~401 (2006)
- Fritz A, "International classification of diseases for oncology (ICD-O). 3rd ed" (2000), World Health Organization
- Maggard MA, "Updated population-based review of carcinoid tumors", Ann Surg, 240, pp.117~122 (2004)
- Garcia-Carbonero R, "Incidence, patterns of care and prognostic factors for outcome of gastroenteropancreatic neuroendocrine tumors(GEP-NETs) : results from the National Cancer Registry of Spain(RGETNE)", Ann Oncol, 21, pp.1794~1803 (2010)
- Rothenstein J, "Neuroendocrine tumors of the gastrointestinal tract : a decade of experience at the Princess Margaret Hospital", Am J Clin Oncol, 31, pp.64~70 (2008)
- Ito T, "Epidemiological study of gastroenteropancreatic neuroendocrine tumors in Japan", J Gastroenterol, 45, pp.234~243 (2010)
- 이현주, "위장관계 신경내분비성 종양의 임상 및 병리학적 특성;65 증례 분석", The Korean Journal of Pathology, 41(3), pp.149~157 (2007), 대한병리학회
- Chetty R., "An overview of practical issues in the diagnosis of gastroenteropancreatic neuroendocrine pathology", Arch Pathol Lab Med, 132, pp.1285~1289 (2008)
- Edge SB, "AJCC cancer staging manual. 7th ed" (2010), Springer
- Arnold R., "Introduction : definition, historical aspects, classification, staging, prognosis and therapeutic options", Best Pract Res Clin Gastroenterol, 19, pp.491~505 (2005)
- Williams ED, "Histological typing of endocrine tumours" (1980), World Health Organization
- 대장내시경연구회, "Clinical Characteristics of Colorectal Carcinoid Tumors", Annals of Coloproctolgy, 27(1), pp.17~20 (2011), 대한대장항문학회
- Jernman J, "The novel WHO 2010 classification for gastrointestinal neuroendocrine tumours correlates well with the metastatic potential of rectal neuroendocrine tumours", Neuroendocrinology, 95, pp.317~324 (2012)
- Hirata I, "Clinicopathological study of colorectal carcinoid tumor, focusing on the indication for endoscopic mucosal resection(EMR)", Stormach Intest, 40, pp.182~193 (2005)
- Tabata H, "Rectal carcinoid tumor 10 mm in diameter accompanied by multiple liver metastases, report of a case", Stormach Intest, 40, pp.215~220 (2005)